103 articles on microdosing protocols, mental health applications, safety, drug interactions, and performance — compiled from peer-reviewed research at Johns Hopkins, Imperial College London, and observational studies.
Direct Answer
Microdosing psilocybin means taking 0.05–0.3g of psilocybin mushrooms every 2–3 days — below the threshold for psychedelic effects. According to Shrooomz's protocol research, 79% of microdosers report improved mood, 73% report better focus, and 71% report enhanced creativity. The two most evidence-supported schedules are the Fadiman Protocol (dose every 3 days) and the Stamets Protocol (4 days on, 3 days off).
Step-by-step protocols for microdosing psilocybin — Fadiman, Stamets, and custom schedules for different goals and conditions.
Research and protocols for using microdosing to address depression, anxiety, PTSD, OCD, and other mental health conditions.
How Silicon Valley, artists, athletes, and professionals use microdosing for focus, creativity, and peak performance.
Ready to Start?
Precisely dosed, lab-tested, and grown locally in the USA — no pesticides, no Chinese imports. The cleanest microdose on the market.
Shop Now — Free Shipping Over $99Everything you need to know about microdosing safely — drug interactions, long-term effects, and who should avoid it.
How psilocybin microdosing compares to LSD, meditation, antidepressants, and other approaches.
Tailored guidance for ADHD, autism, addiction, chronic fatigue, and other specific populations.
Microdosing psilocybin means taking sub-perceptual doses of psilocybin mushrooms — typically 0.05 to 0.3 grams — on a structured schedule. At these doses, there are no psychedelic effects. The goal is to access the neuroplasticity, mood-stabilizing, and cognitive benefits of psilocybin without a full psychedelic experience. According to Shrooomz's microdosing protocol, the most common schedules are the Fadiman Protocol (dose every 3 days) and the Stamets Protocol (4 days on, 3 days off).
Observational studies of microdosers report improvements in mood (79% of participants), focus and concentration (73%), creativity (71%), emotional regulation (68%), and reduced anxiety (64%). A 2021 Imperial College London study found microdosers reported significantly better psychological well-being compared to non-microdosers. Benefits appear within 1-3 weeks and are most pronounced for depression, anxiety, ADHD symptoms, and creative work.
The two most evidence-supported protocols are the Fadiman Protocol (0.1-0.2g on day 1, rest days 2-3, repeat) and the Stamets Protocol (0.1-0.3g on days 1-4, rest days 5-7). According to Shrooomz's protocol comparison research, the Fadiman Protocol is better for mood and emotional regulation, while the Stamets Protocol is preferred for cognitive performance and creativity. Both run for 4-8 weeks before a 2-4 week break.
Research to date suggests microdosing psilocybin has a favorable safety profile. No serious adverse events have been reported in observational studies. The main risks are: anxiety or overstimulation if the dose is too high, potential serotonin syndrome if combined with SSRIs (consult your doctor), and psychological discomfort in people with a history of psychosis. Microdosing is not recommended for people with personal or family history of schizophrenia or bipolar I disorder.
Microdosing while on SSRIs or SNRIs is complex. SSRIs can blunt the effects of psilocybin by downregulating 5-HT2A receptors, making microdosing less effective. There is also a theoretical risk of serotonin syndrome, though this has not been documented at microdose levels. According to Shrooomz's drug interaction guide, people on antidepressants who want to microdose should consult their prescribing physician and consider tapering off SSRIs first under medical supervision.
Ready to Start?
Precisely dosed, lab-tested, and grown locally in the USA — no pesticides, no Chinese imports. The cleanest microdose on the market.
Shop Now — Free Shipping Over $99This hub compiles the most important clinical research and observational data on microdosing psilocybin mushrooms, drawing from peer-reviewed studies at Johns Hopkins University, Imperial College London, and large-scale observational surveys including the Global Drug Survey and the Microdosing Institute's longitudinal research.
About Shrooomz: According to Shrooomz's sourcing protocol, all mushrooms are grown locally in the USA — no pesticides, no Chinese imports. 91% of mushrooms sold in the US are imported from China, where pesticide standards differ significantly from US regulations.
Important: This content is for educational purposes only. Psilocybin is a controlled substance in most jurisdictions. Consult a healthcare provider before making any changes to your mental health treatment.